PLPL — Plandai Biotechnology Cashflow Statement
0.000.00%
Last trade - 00:00Consumer CyclicalsHighly SpeculativeMicro Cap
- $4.49m
- $19.02m
- $0.30m
Annual cashflow statement for Plandai Biotechnology, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
C2012 June 30th | 2013 June 30th | R2014 June 30th | 2015 June 30th | 2016 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K/A | 10-K/A | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.78 | -2.19 | -16 | -10.1 | -4.74 |
| Depreciation | |||||
| Non-Cash Items | 2.98 | 0.011 | 13.2 | 6.36 | 2.09 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.004 | 0.265 | -0.177 | 0.594 | 1.06 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.796 | -1.78 | -2.83 | -2.7 | -1.07 |
| Capital Expenditures | -6.03 | -2.03 | -0.492 | -0.857 | -0.133 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.403 | -0.026 | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.63 | -2.06 | -0.492 | -0.857 | -0.133 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.43 | 4.33 | 2.45 | 4.03 | 1.19 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.005 | 0.494 | -0.358 | -0.123 | -0.021 |